Can early intervention for asymptomatic severe aortic stenosis offer both better outcomes and value for money?
A new publication in Frontiers in Cardiovascular Medicine explores the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared with clinical surveillance for people with asymptomatic severe aortic stenosis in the Kingdom of Saudi Arabia.
The economic evaluation, co-authored by YHEC's Madison Montgomery, Heather Davies, Reagan Davis and Lucy Hillcoat, adapted a Markov model using evidence from the EARLY TAVR clinical trial and published literature.
The findings suggest that early TAVI could deliver improved health outcomes while reducing healthcare costs compared with clinical surveillance, with a 97.3% probability of being cost-effective.
The study highlights the importance of economic modelling in assessing the potential value of new treatment approaches and informing healthcare policy in different healthcare settings.
Read the full publication: frontiersin.org/journals/cardi…
#HealthEconomics #CostEffectiveness #HTA #TAVI #YHEC
A new publication in Frontiers in Cardiovascular Medicine explores the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared with clinical surveillance for people with asymptomatic severe aortic stenosis in the Kingdom of Saudi Arabia.
The economic evaluation, co-authored by YHEC's Madison Montgomery, Heather Davies, Reagan Davis and Lucy Hillcoat, adapted a Markov model using evidence from the EARLY TAVR clinical trial and published literature.
The findings suggest that early TAVI could deliver improved health outcomes while reducing healthcare costs compared with clinical surveillance, with a 97.3% probability of being cost-effective.
The study highlights the importance of economic modelling in assessing the potential value of new treatment approaches and informing healthcare policy in different healthcare settings.
Read the full publication: frontiersin.org/journals/cardi…
#HealthEconomics #CostEffectiveness #HTA #TAVI #YHEC